A randomized phase II study comparing erlotinib versus erlotinib with alternating chemotherapy in relapsed non-small-cell lung cancer patients: the NVALT-10 study(dagger)

JG Aerts, H. Codrington, N.A.G. Lankheet, S. Burgers, B. Biesma, A.M.C. Dingemans, A.D. Vincent, O. Dalesio, H.J.M. Groen, E.F. Smit

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)2860-2865
JournalAnnals of Oncology
Issue number11
Publication statusPublished - 2013

Cite this